HomeBUSINESS
BUSINESS

Shionogi, UMN Pharma Conclude Capital Alliance; Tie Up in Infectious Disease Field
(Nov.2.2017)

Shionogi and the biotech startup UMN Pharma on October 31 announced a capital investment and business alliance agreement. Under the agreement, UMN Pharma will allocate 600,000 shares of common stock and a first issuance of convertible bonds with stock acquisition rights to Shionogi, which is expected to invest around 1.6 billion yen for the acquisition ...
(LOG IN FOR FULL STORY)

News Calendar